DJIA 17,098.45 18.88 0.11%
NASDAQ 4,580.27 22.58 0.50%
S&P 500 2,003.37 6.63 0.33%
market minute promo

ZIOPHARM Oncology (NASDAQ: ZIOP)

3.23 0.08 (2.54%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

ZIOP $3.23 2.54%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $3.16
Previous Close $3.15
Daily Range $3.15 - $3.23
52-Week Range $2.87 - $5.58
Market Cap $325.4M
P/E Ratio -7.33
Dividend (Yield) $0.00 (0.0%)
Volume 337,934
Average Daily Volume 480,425
Current FY EPS -$0.40

Sector

Healthcare

Industry

Drugs

ZIOPHARM Oncology (ZIOP) Description

ZIOPHARM Oncology Inc. is a biopharmaceutical company engaged in the development and commercialization of small molecule and synthetic biology approaches to new cancer therapies. Website: http://www.ziopharm.com/

News & Commentary

This Week in Biotech: PTC Therapeutics Surprises, Isis' Data Dazzles, and Provectus Sinks

Four positive clinical updates, a billion-dollar licensing deal, a surprising positive opinion for one company in the EU, and a rough NYSEArca debut for one biopharma are this week's top biotech stories.

Week In Review: PW Medtech Pays $130 Million For Fellow China Medical Device Company

Who Will Be Swimming Naked When The Tide Goes Out? (Part IV)

Ziopharm: Pipeline Expansion And Data Updates To Drive Near-Term Upside

Ziopharm Joins The CAR Crowd

ZIOPHARM Announces Expansion Of Ground-Breaking Synthetic Immuno-Oncology Programs With Intrexon And

ZIOPHARM Announces Expansion Of Ground-Breaking Synthetic Immuno-Oncology Programs With Intrexon And Clinical Program Update

Why Ziopharm Looks Worth Adding To Your Biotechnology Portfolio Pipeline

The Sirens Of Ziopharm

Can the Uptrend Continue for ZIOPHARM (ZIOP)? - Tale of the Tape

Mid-Morning Market Update: Markets Gain On Jobs Data; VeriFone Earnings Beat Estimates

Ziopharm - A Stock Worth Owning To Benefit Your Portfolio This Year And Beyond

See More ZIOP News...

ZIOP's Top Competitors

ZIOP $3.23 (2.54%)
Current stock: ZIOP
AMGN $139.38 (0.50%)
Current stock: AMGN
GILD $107.56 (0.05%)
Current stock: GILD
BIIB $343.04 (0.53%)
Current stock: BIIB